Akouos, Inc. announced the appointment of Stacy Price as chief technical officer. Ms. Price brings to Akouos more than 25 years of experience managing clinical and commercial biotechnology manufacturing and technical operations for a wide range of therapeutic modalities, including gene therapy. At Akouos, she will be responsible for the strategy and operations of vector development and manufacturing, as well as device development and engineering. Ms. Price was most recently senior vice president of technical operations at Ziopharm Oncology, where she was accountable for development and delivery of CMC strategy for cell and combination gene therapy products, and for establishing the company?s clinical manufacturing capability. Prior to Ziopharm, Ms. Price was head of pharmaceutical development operations at Shire, where she led CMC program management as well as laboratory and pilot plant operations, and set overall operations strategy. She holds a Master of Science in Biochemical Engineering from Tufts University.